SCHEMBL26099558

SCHEMBL26099558

CC(=O)Cc1ncccc1C(=O)OC(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.40
ADRA1A P35348 1/20 0.40
ADRA1B P35368 1/20 0.40
MAPT P10636 3/20 0.39
TDP1 Q9NUW8 3/20 0.37
CHRM2 P08172 1/20 0.36
CHRM4 P08173 1/20 0.36
CHRM5 P08912 1/20 0.36
CHRM1 P11229 1/20 0.36
CHRM3 P20309 1/20 0.36
MAPK1 P28482 1/20 0.36
P2RX7 Q99572 1/20 0.36
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
PKM P14618 1/20 0.35
TSHR P16473 1/20 0.35
CASP3 P42574 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5778792 0.88 KDM4E (0.41) POLBADRA1AADRA1BMAPTTDP1
SCHEMBL7301123 0.84 POLB (0.41) POLBADRA1AADRA1BMAPTTDP1
SCHEMBL5774784 0.83 MAPT (0.56) MAPTMAPK1ALDH1A1HSD17B10L3MBTL1
SCHEMBL26101464 0.81 TSHR (0.54) MAPTMAPK1ALDH1A1HPGDHSD17B10
SCHEMBL25718894 0.78 KDM4E (0.53) MAPTTDP1P2RX7KDM4EALDH1A1
SCHEMBL2633213 0.76 P2RX7 (0.56) POLBADRA1AADRA1BMAPTTDP1
SCHEMBL30441012 0.76 KDM4E (0.46) POLBADRA1AADRA1BMAPTTDP1
SCHEMBL163493 0.76 POLB (0.45) POLBADRA1AADRA1BMAPTTDP1
SCHEMBL2659360 0.75 POLB (0.60) POLBTDP1ALDH1A1L3MBTL1PKM
SCHEMBL8422472 0.75 POLB (0.44) POLBADRA1AADRA1BMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260132127-A1 NOVEL SPIRO COMPOUND MITSUBISHI TANABE PHARMA CORPORATION (JP) 2026-05-14 US disclosed
CN-118176179-A Novel spiro compounds 田边三菱制药株式会社 2024-06-11 CN disclosed
WO-2023074847-A1 NOVEL SPIRO COMPOUND 田辺三菱製薬株式会社 2023-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132127-A1 NOVEL SPIRO COMPOUND TRHR, NR3C2, THRB POLB 4761/4885ADRA1A 107/4885ADRA1B 86/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.